VALUE PROPOSITION
VascuX is a remote surveillance solution for Chronic Kidney Disease hemodialysis patients. Our implantable vascular access graft (AVG) delivers clinically actionable data as real-time early warning diagnostics. We can detect and predict graft failure to maximise implant lifespan and reduce patient need. Moreover, the device offers a remote therapy solution to maintain graft patency and to provide real-world cost savings.
WHO ARE WE?
We are a pre spin out team of vascular biologists and bioengineers developing for the next generation of ACTIVE self-reporting cardiovascular implantables seeking investment.
THE PROBLEM
In 2023, the NHS estimated that Chronic Kidney Disease (CKD) costs £7 billion pA with £34,000 per patient per year.
The total economic burden of CKD in the USA is a staggering $114 Billion, with CKD patients accounting for 1% of patients but consuming 8% of the entire Medicare budget. VascuX self-reporting implants provide an innovative cost-effective solution.
THE SOLUTION
We have developed a non-invasive diagnostic and therapeutic technology integrated into your implant that wirelessly reports impending vascular complications in real-time with option to provide remote therapeutic intervention.
TIMELINE
DESIGN & DEVELOPMENT
COMMERCIALISATION
THE TECHNOLOGY
DETECTION
Precision sensors integrated into our vascular implants provide an in depth assessment of a patients vascular implant outside the traditional hospital environment
INTERVENTION
Using our sensor technology we can detect the very earliest pathological changes before they compromise a patient’s implant and then effect a discrete therapy
COMMUNICATION
Our plug-and-play electronics allow multiple sensors to wirelessly send and receive data to our secure cloud-based servers that can be accessed by your clinician to schedule appointments only for those patients that need them